Keyser Bioscience: Net profit in 2025 is 561 million yuan, a year-on-year increase of 14.68%.

Kaisai Biotechnology announced that in 2025, its operating income was 3.295 billion yuan, an increase of 11.40% year-on-year. Net profit was 561 million yuan, an increase of 14.68% year-on-year. The company plans to distribute profits based on the total share capital registered on the record date of equity distribution. It will distribute a cash dividend of 4.5 yuan per 10 shares to all shareholders. The company will not issue bonus shares or increase capital reserves by converting them into shares.